참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | Oxalyl chloride | HCID 65578 | — |
| 반응물 | 3,4-Dichlorocinnamic acid | HCID 688027 | — |
| 반응물 | 1,4-Diazepan-5-one | HCID 2737264 | — |
| 촉매 | Dimethylformamide | HCID 6228 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | 1-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-[1,4]diazepan-5-one | HCID 62044921 | 64.9% |
반응 단계
A solution of 9.77 g (43.65 mmol) of (E)-3,4-dichlorocinnamic acid in 250 ml of CH2Cl2 was treated at RT with 3 drops of DMF. 4.15 ml (48.02 mmol, 1.1 eq) of oxalyl chloride in 30 ml CH2Cl2 were added dropwise and stirring was continued for 3 h. The solution was evaporated, redissolved in 170 ml of CH2Cl2, cooled (0° C.) and treated with a solution of 4.48 g (39.29 mmol, 0.9 eq) of 2,3,6,7-tetrahydro-(1H)-1,4-diazepin-5(4H)-one and 12.17 ml (87.30 mmol, 2 eq) of triethylamine in 80 ml of CH2Cl2. The reaction was warmed up over night to RT, then partitioned between CH2Cl2/MeOH 9:1 (×3)/ aqueous 10% KHSO4, the organic phases were washed with aqueous saturated NaHCO3 and aqueous 10% NaCl, dried over Na2SO4 and evaporated. The residue was dissolved and evaporated with toluene and crystallized with CH2Cl2/Et2O to give 7.99 g (58%) of the title compound as white solid. MS: 312.8 (MH+, 2Cl).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07632829B2 |
|---|
| 출처 데이터셋 | uspto-grants-2009_12 |
|---|
| ORD ID | ord-26b01004002f403a85a04c4e674cf6f2 |
|---|
| 출처 메모 | uspto-grants-2009_12 |
|---|